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The critical impact that microbiota have on health and disease makes the interaction between host
and microbiome increasingly important as we evaluate therapeutics. Here, we highlight growing
evidence that, beyond disease, microbes also affect the most fundamental of host physiological
phenotypes, the rate of aging itself.As you look in the mirror, you may only see yourself staring back,
but in reality, you are not alone; you share your body with trillions
of others. Contained on and within our bodies thrives a dynamic
population of microbes that form a ‘‘metaorganism’’ comprising
ten bacterial cells for every one of our own. Despite coevolving in
the presence of this ‘‘microbiome’’ for 500million years (Cho and
Blaser, 2012), only recently have advances in sequencing tech-
nology allowed us to appreciate the complexities of this relation-
ship and the manner by which genomes within metaorganisms
interact and affect one another. Interindividual variations in the
microbiome impact multiple human pathologies, from metabolic
syndrome to cancer (Cho and Blaser, 2012). However, new data
in invertebrate systems indicate that microbes extend their
effects beyond host pathology to systemic modulation of the
rate of aging.
The gut microbiome comprises a complex community of bac-
terial species that live within intestines of coelomate animals.
Historically, the influence of gut microflora on host health has
focused on the two extremes of the relationship: pathogenesis
and symbiosis. Canonical examples of symbiotic host/microbe
relationships include the reliance of some herbivores on gut flora
for efficient digestion of cellulose. However, themajority of intes-
tinal microbes are neither pathogenic nor classically symbiotic
but instead ‘‘commensal,’’ meaning that their effect is nonharm-
ful and neutral. Advances in high-throughput sequencing have
facilitated the characterization of these diverse populations of
commensal bacteria, defining the metagenome—the ensemble
of host and microbiota DNA—and by extension, the metatran-
scriptome, proteome, and metabolome. With endeavors such
as the Human Microbiome Project just beginning (Cho and
Blaser, 2012), research into the complexity of mammalian micro-
biome dynamics is in its infancy. Assigning causality to effects
of the microbiome in mammalian systems is expensive and
technically challenging and requires microbe-free husbandry
conditions and gnotobiotic mice with defined and controlled
microbiota (Cho and Blaser, 2012).
Invertebrate model systems such as the fruit fly Drosophila
melanogaster and the nematode worm Caenorhabditis
elegans (C. elegans) also live in the presence of microbiota both
in nature and in the laboratory (Ren et al., 2007; Zhang and
Hou, 2013). Due to their genetic tractability and inexpensive408 Cell 156, January 30, 2014 ª2014 Elsevier Inc.husbandry, invertebrate studies allow direct causality to be
assigned to the presence or absence of microbiota. Because of
their short lifespans,Drosophila andC. elegans are also powerful
models for studying genetic pathways that modulate the aging
process. The ultimate goal of this research is to develop novel
therapeutics with beneficial impacts on overall health in old
age, complementing disease-centric approaches that focus on
proximal determinants of individual pathologies. This work has
uncoveredconservedgenes thatmodulate healthy aging in inver-
tebrates andmammals and are linked to extreme longevity in hu-
mans (Kenyon, 2010), including the insulin/IGF-1 like signaling
(IIS) pathway, the target of rapamycin (TOR), and AMP-activated
protein kinase (AMPK). However, little attention has been paid to
how the microbial environment and the microbiome itself might
affect the ability of these interventions to promote longevity.
Here, we review examples of microbiota in invertebrates directly
and indirectly influencing the host genome to affect longevity and
discuss the impact that these emerging data have on the field of
aging research.
Direct Interspecies Signaling and Aging
Given the proximity of microbes and host within the metaorgan-
ism, diffusible molecules originating in bacteria can directly
affect cells in the host (Ryan and Dow, 2008). Recent work sug-
gests that this interspecies signaling can impact host aging rate.
C. elegans are commonly grown ‘‘monoxenically’’ in coculture
with nonpathogenic strains of E. coli ‘‘OP50’’ bacteria. E. coli
act as nutrition for the worm, providing mandatory nutrients
and essential components for life that the nematode cannot
synthesize de novo. Although not considered pathogenic,
E. coli OP50 do proliferate inside of older animals, and raising
C. elegans on nondividing bacterial lawns suppresses this infec-
tion and increases worm lifespan (Zhang and Hou, 2013). In
young worms, however, E. coli are mechanically broken down
before entering the gut and do not live in the animal as a true
microbiome. Despite this, it is becoming apparent that, beyond
their role as a nutrient source and potential pathogen, E. coli
secrete diffusible molecules, including metabolites and small
RNAs that can directly impact C. elegans aging.
An example of a direct interspecies signal secreted by mi-
crobes that can promote longevity is nitric oxide (NO) (Gusarov
Figure 1. Microbe Modulation of Inverte-
brate Aging and Physiology
(A) Bacterial-derived signals NO and ncRNAs
regulate C. elegans longevity.
(B) Metformin increases C. elegans lifespan via
effects on bacterial folate metabolism.
(C) L. plantarum drive Drosophila growth under
low-nutrient conditions via the longevity modu-
lator TOR.
(D) Different bacterial species elicit specific tran-
scriptional responses in C. elegans.et al., 2013). NO is a small, short-lived free radical that affects the
activity of proteins both directly and indirectly via posttransla-
tional modifications. As a critical signaling molecule, NO has
been implicated in multiple functions, including neurotransmis-
sion, immunity, and cardiovascular function (Gusarov et al.,
2013). C. elegans are rare among eukaryotes, as they cannot
produce their own NO because they lack NO synthase. Gusarov
et al. therefore speculated that worms might be utilizing NO
produced from the bacteria within their microenvironment. Sup-
porting their hypothesis, culturing C. elegans with NO-deficient
Bacillus subtilis shortens their lifespan, whereas exogenous sup-
plementation of NO increases it. Strikingly, an in vivo fluorescent
sensor detected NO in multiple C. elegans tissues, suggesting
that it acts as a bona fide interspecies longevity signal. RNA
sequencing analysis of worms fed NO identified specific tran-
scriptional responses regulated by two transcription factors,
DAF-16/FOXO and heat shock factor 1 (HSF-1), both known to
mediate lifespan (Kenyon, 2010). Worms lacking DAF-16/
FOXO or HSF-1 do not respond to the life-prolonging effects of
bacterial NO, meaning that bacterial NO modulates C. elegans
lifespan via effects on host transcription (Figure 1A).
Not all signals from bacteria have a positive effect on worm
longevity. RNA interference (RNAi), a mechanism by which
short double-stranded RNAs promote degradation of matching
messenger RNA, was first discovered in C. elegans. Feeding
E. coli expressing a double-stranded C. elegans RNA sequence
efficiently suppresses the worm gene (Liu et al., 2012). Interest-
ingly, this synthetic laboratory systemmay bemirroring a natural
communication between microbe and worm genomes. Liu et al.
(2012) found that small noncoding RNAs (ncRNAs) expressed
endogenously by E. coli can modulate C. elegans behavior and
longevity. Feeding worms E. coli deficient in the ncRNA DsrA
significantly increases their lifespan. The worm gene F42G9.6Cell 156bears sequence complementary to
DsrA, and mutating this gene shortens
lifespan and makes worms refractory to
the effects of DsrA. Moreover, F42G9.6
expression is upregulated in long-
lived IIS mutants, and overexpressing
F42G9.6 slows aging (Liu et al., 2012)
(Figure 1A). E. coli modulate longevity of
the worm by hijacking innate RNAi ma-
chinery, as worms incapable of RNAi are
resistant to the effects of DsrA. Cross-
species small RNA regulation has yet to
be observed between microbes andmammals. However, microRNAs derived from plants are present
in human and rodent serum and tissues (Zhang et al., 2012), sug-
gesting such interspecies communication is feasible.
Microbial Metabolites and Host Aging
Commensal bacteria can affect the nutrient landscape of the
host—the majority of metabolites in human plasma are
microbe-derived (Nicholson et al., 2012)—but recent work
suggests that bacterial-derived metabolites can affect host
longevity. Metformin is the most widely prescribed treatment
for metabolic disease and has gained attention as a potential
prolongevity molecule, as one of its key targets is AMPK, a
conserved energy sensor implicated in lifespan extension by
dietary restriction (DR) (Kenyon, 2010). Feeding worms metfor-
min robustly increases lifespan in an AMPK-dependent manner.
Surprisingly, this response is indirectly mediated by the effect of
the drug on bacteria, rather than on the worms themselves. Met-
formin has no effect on worms cultured axenically (with no bac-
teria) or on lawns of killed bacteria (Cabreiro et al., 2013) yet
extends lifespan of worms fed live but antibiotic-arrested bacte-
ria, ruling out suppression of bacterial pathogenicity. Metformin
suppresses folate metabolism specifically in E. coli, and feeding
worms either the antibiotic trimethoprim, which inhibits dihydro-
folate reductase in bacteria, or E. coli mutants with suppressed
folate metabolism (Virk et al., 2012) also increases lifespan.
Reduced folate metabolism decreases methionine content of
bacteria, and this effect is causal tometformin-induced longevity
in C. elegans. Although reduced dietary methionine is known to
promote longevity in both mammals and Drosophila (Kenyon,
2010), these data add a new level of complexity into how prolon-
gevity drugs might mediate effects on an organism indirectly
via affecting metabolites in associated microbiota (Figure 1B).
Metformin increases lifespan in rodents (Martin-Montalvo et al.,, January 30, 2014 ª2014 Elsevier Inc. 409
2013), and a side effect of metformin treatment in humans is
reduced folate levels (Cabreiro et al., 2013). Whether physiolog-
ical effects of metformin function via microbe folate metabolism
warrants investigation.
Effects of Axenic Culture on the Host
Culturing worms axenically robustly increases their lifespan
(Houthoofd et al., 2002). Yet because bacteria are also the
food source, determining relative contributions of DR versus mi-
crobial presence on worm lifespan is challenging. An alternative
model system is Drosophila, which are cultured with antifungal
agents but are not kept axenically and host a bona fide micro-
biome of up to 20 different bacterial species (Ren et al., 2007).
Unlike worms, the effect of associated bacteria on Drosophila
lifespan is less clear and may depend upon the precise compo-
sition of the microbiota population. Early reports suggested that
culturing Drosophila axenically shortened lifespan, with the
presence of bacteria within the first week of adult life slowing
aging (Brummel et al., 2004). However, follow-up studies
observed no effect of microbiota on aging (Ren et al., 2007),
and such variation highlights the need to consider the holo-
biome when examining genetic modifiers of aging. Both groups
performed lifespans using the same Canton-S strain, yet the
composition of the microbiome associated with those strains
differed, likely due to differences in husbandry (Ren et al.,
2007). One explanation is that the Brummel study housed
Drosophila with specific symbiotic microbiota, which likely
benefited them, whereas the Ren study had only neutral
commensal microbes. The complexity of the microbiotic
component therefore should not be ignored when interpreting
differences in data between laboratories studying the effects
of single genes on aging.
Bacteria can also affect the capacity of flies to sense nutrients
(Storelli et al., 2011). Storelli et al. compared growth of
Drosophila larvae on nutrient-rich versus nutrient-poor diets,
with and without microbiota. Bacteria had no effect on the
growth of larvae replete with nutrients. However, the growth
retardation of larvae on nutrient-poor food was exaggerated in
the absence of bacteria. The ability of microbes to promote
growth in low-nutrient conditions is due to one specific species,
Lactobacillus plantarum, which can promote growth to adult-
hood of larvae given no dietary yeast, a condition that usually
arrests development. L. plantarum therefore overrides the host’s
ability to match growth to nutrient availability and does so via up-
regulation of the TOR pathway. Flies overexpressing the inhibitor
of TOR complex 1 are resistant to the effects of L. plantarum on
growth (Storelli et al., 2011). Given that suppression of TOR is
known to promote longevity across species (Kenyon, 2010), it
will be of great interest to determine whether L. plantarummight
regulate aging similar to its effects on growth (Figure 1C).
Whether microbiome composition affects the capacity of the
host to utilize nutrients has implications for the effects of diet
and DR on aging. Transplanting microbiota from genetically
obese ob/ob mice into germ-free lean C57BL/6J mice induces
obesity in the recipients compared to controls despite similar
caloric intake (Turnbaugh et al., 2006), suggesting that their abil-
ity to glean nutrients is affected by themicrobes. How this type of
interaction might affect lifespan extension via DR has yet to be410 Cell 156, January 30, 2014 ª2014 Elsevier Inc.explored. Might transplanting a ‘‘dietary-restricted microbiome’’
into ad libitum fed mice promote healthy aging?
The presence of microbiota at the interface of the gut epithe-
lium also has systemic effects on host aging. In Drosophila,
maintaining balance between intestinal stem cell (ISC) quies-
cence and proliferation is critical for intestinal function and
organismal longevity. Tipping the balance toward quiescence
limits intestinal rejuvenation, whereas ISC overproliferation
causes epithelial dysplasia (Jasper and Jones, 2010). As flies
age, hyperproliferation of ISCs leads to intestinal dysfunction,
but this does not occur in animals reared axenically (Guo et al.,
2013). Aging induces activation of intestinal genes regulated by
the single fly FOXO transcription factor. Specific FOXO inhibition
in intestinal epithelial cells (ECs) prevents the effects of both age
and microbiota on ISC hyperproliferation (Guo et al., 2013). The
peptidoglycan recognition protein PGRP-SC2 is a FOXO target
that reduces with age, and the beneficial effects of FOXO
knockdown in ECs is not seen in flies with reduced PGRP-S2.
Finally, PGRP-SC2 overexpression in Drosophila ECs signifi-
cantly increases lifespan dependent upon the presence of
commensal bacteria in the gut. Together, this highlights how
host and bacteria interactions extend beyond intestinal homeo-
stasis to influence systemic health and longevity.
Microbial Species-Specific Effects on Host Aging
Beyond the presence or absence of bacteria, specific bacterial
species can have unique effects on host physiology. Worms
fed Comamonas DA1877, a bacterial species found in their nat-
ural soil habitat, have faster development time, reduced fecun-
dity, and shorter lifespans compared to those fed the standard
laboratory E. coli OP50 diet. A comparison of gene expression
on the two diets led to the identification of acdh-1 as being spe-
cifically induced by OP50, but not DA1877. MacNeil et al. devel-
oped an acdh-1-promoter-based in vivo fluorescent reporter as
a ‘‘diet’’ sensor. Interestingly, worms are acutely sensitive to
signals emanating from DA1877; diluting OP50 with only 0.1%
DA1877 still suppressed the reporter and induced similar
transcriptional responses to DA1877 alone (MacNeil et al.,
2013). Watson et al. performed forward and reverse genetic
screens for genes affecting the GFP sensor, identifying a com-
plex mitochondrial metabolic and nuclear gene regulatory
network. Hence, DA1877 can induce whole-scale metabolic
responses in the worm to modulate development and aging
(Watson et al., 2013) (Figure 1D). Several enzymes identified in
the screens have human orthologs that, when mutated, lead
to inborn errors of metabolism. If gut microbes can remodel
metabolic networks in human hosts as they do in C. elegans,
might prebiotics offer candidate therapies to combat metabolic
defects?
The effects of single gene mutations on lifespan can also
depend upon the presence of specific bacteria. TOR is found in
two complexes, and in C. elegans, mutations in the TOR com-
plex-2-specific factor Rictor have bacterial-specific effects on
longevity. Rictor mutants are short lived when cultured on stan-
dard B-derived OP50 bacteria, yet when grown on the K12-
derived E. coli HT115, they are long lived by 76% (Soukas
et al., 2009). In contrast, worms harboring mutations in the alde-
hyde dehydrogenase gene alh-6 are short lived on OP50 yet
normal lived onHT115 (Pang andCurran, 2014). Both of these ef-
fects were assigned to nutritional compositions of the bacteria,
yet alternative explanations involving differential metabolites or
signals produced in the alternateE. coli strains have not been fully
explored. Although wild-type worms do not have markedly
different lifespans on B- versus K12-derived bacteria, they do
have different lipid profiles, which reflect the different lipid
compositions of the bacteria (Brooks et al., 2009). This effect
on worm lipid composition is abolished in animals lacking the
peptide transporter PEPT-1 (Brooks et al., 2009). Therefore, a
peptide signal might at least in part be mediating the effects of
bacteria on worm physiology beyond nutritional differences.
Several whole-genome RNAi screens in C. elegans have
successfully identified key longevity targets, yet all have been
performed using HT115. Given emerging data on worm/microbe
interactions, perhaps using a single, uniform microbial back-
ground is a limited strategy, and the search for longevity genes
should be extended on alternative microbial backgrounds.
Outlook
Collectively, these studies represent the beginning of the
exploration into how genomes within metaorganisms interact
to influence host longevity. Although it is too soon to know how
invertebrate resultswill translate tomammalian aging, the studies
highlight a need to consider the holobiome when thinking about
the impact of single gene manipulations on longevity—context
is key. Anecdotal evidence for this perhaps already exists for
mammalian aging. Snell dwarfmice, deficient in thyroid hormone,
are long lived by up to 50%, yet decades earlier, thesemice were
touted as a model of rapid aging and progeria (Flurkey et al.,
2002). The difference did not lie in the mice but, rather, in their
environment. As husbandry facilities improved, a once progeric
mouse became a long-lived hope. Although husbandry factors
other than microbes may have mediated this transition, it is a
striking reminder of how environmental context can drastically
alter the effect of a single mutation on aging.
Aging research aims to find single interventions with beneficial
effects on multiple age-related disorders by impacting the plas-
ticity of the aging process. As humans age, the composition of
our microbiome changes (Yatsunenko et al., 2012). If micro-
biome dynamics severely alter the effects of single gene
interventions, might we be targeting the wrong genome in the
metaorganism? Perhaps alongside focusing on the genetic regu-
lation of healthy aging, we should pay equal attention to prebiotic
regulation of longevity as an alternate means to the same end.
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